rxstat › Classes › Posterior Pituitary Lobe Hormones
Posterior Pituitary Lobe Hormones: shortage status in Canada
1 of the 5 posterior pituitary lobe hormones rxstat tracks is currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Desmopressin (Ddavp) Partial shortage 1 of 13 reported products affected · est. return Nov 6, 2026
Carbetocin (Duratocin) No current shortage
Desmopressin (Nocdurna) Discontinued 0 of 3 reported products affected
Oxytocin No current shortage
Vasopressin (Pressyn Ar) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.